SE422057B - Forfarande for framstellning av vissa omega-substituerade omega-nor-13,14-dehydro-prostaglandiner - Google Patents
Forfarande for framstellning av vissa omega-substituerade omega-nor-13,14-dehydro-prostaglandinerInfo
- Publication number
- SE422057B SE422057B SE7509764A SE7509764A SE422057B SE 422057 B SE422057 B SE 422057B SE 7509764 A SE7509764 A SE 7509764A SE 7509764 A SE7509764 A SE 7509764A SE 422057 B SE422057 B SE 422057B
- Authority
- SE
- Sweden
- Prior art keywords
- omega
- prostaglandines
- dehydro
- procedure
- substituted
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D307/93—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems condensed with a ring other than six-membered
- C07D307/935—Not further condensed cyclopenta [b] furans or hydrogenated cyclopenta [b] furans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C405/00—Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
- C07D309/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
- C07D309/08—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D309/10—Oxygen atoms
- C07D309/12—Oxygen atoms only hydrogen atoms and one oxygen atom directly attached to ring carbon atoms, e.g. tetrahydropyranyl ethers
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/28—Phosphorus compounds with one or more P—C bonds
- C07F9/38—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
- C07F9/40—Esters thereof
- C07F9/4003—Esters thereof the acid moiety containing a substituent or a structure which is considered as characteristic
- C07F9/4018—Esters of cycloaliphatic acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/28—Phosphorus compounds with one or more P—C bonds
- C07F9/54—Quaternary phosphonium compounds
- C07F9/5407—Acyclic saturated phosphonium compounds
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/553—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having one nitrogen atom as the only ring hetero atom
- C07F9/564—Three-membered rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/553—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having one nitrogen atom as the only ring hetero atom
- C07F9/576—Six-membered rings
- C07F9/58—Pyridine rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Furan Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Saccharide Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IT27654/74A IT1053781B (it) | 1974-09-25 | 1974-09-25 | Omega nor cicloalcil 13.14 deidro prostaglandine |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| SE7509764L SE7509764L (sv) | 1976-03-26 |
| SE422057B true SE422057B (sv) | 1982-02-15 |
Family
ID=11222055
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SE7509764A SE422057B (sv) | 1974-09-25 | 1975-09-03 | Forfarande for framstellning av vissa omega-substituerade omega-nor-13,14-dehydro-prostaglandiner |
Country Status (24)
| Country | Link |
|---|---|
| US (2) | US4035415A (OSRAM) |
| JP (2) | JPS5839156B2 (OSRAM) |
| AT (1) | AT351184B (OSRAM) |
| BE (1) | BE832983A (OSRAM) |
| CA (1) | CA1083569A (OSRAM) |
| CH (1) | CH617186A5 (OSRAM) |
| CS (1) | CS191276B2 (OSRAM) |
| CY (1) | CY954A (OSRAM) |
| DE (1) | DE2539116C2 (OSRAM) |
| DK (1) | DK155316C (OSRAM) |
| FI (1) | FI63932C (OSRAM) |
| FR (2) | FR2285866A1 (OSRAM) |
| GB (1) | GB1483880A (OSRAM) |
| HK (1) | HK42478A (OSRAM) |
| HU (1) | HU174287B (OSRAM) |
| IL (1) | IL48043A (OSRAM) |
| IT (1) | IT1053781B (OSRAM) |
| KE (1) | KE2851A (OSRAM) |
| MY (1) | MY7800321A (OSRAM) |
| NL (1) | NL187354C (OSRAM) |
| NO (1) | NO146357C (OSRAM) |
| SE (1) | SE422057B (OSRAM) |
| SU (1) | SU652889A3 (OSRAM) |
| ZA (1) | ZA755420B (OSRAM) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU501803B2 (en) * | 1975-03-21 | 1979-06-28 | Farmitalia Carlo Erba S.P.A. | Fluoro-prostaglandins |
| DE2655004C3 (de) * | 1976-12-02 | 1980-06-19 | Schering Ag, 1000 Berlin Und 4619 Bergkamen | Verfahren zur Herstellung von bicyclischen Laktonen |
| IT1088966B (it) * | 1977-11-15 | 1985-06-10 | Erba Carlo Spa | 13,14-dideidro-prostaglandine |
| CH656877A5 (de) * | 1981-11-27 | 1986-07-31 | Erba Farmitalia | Optisch aktive oder racemische prostaglandinderivate. |
| EP1348437A3 (en) * | 1988-09-06 | 2003-11-19 | Pharmacia Aktiebolag | Prostaglandin derivatives for the treatment of glaucoma or ocular hypertension |
| DE4024347A1 (de) * | 1990-07-27 | 1992-01-30 | Schering Ag | Cyclopentanderivate, verfahren zu ihrer herstellung und ihre pharmazeutische verwendung |
| US5741810A (en) * | 1996-02-29 | 1998-04-21 | Allergan | Cyclopentane heptan(ene)oic acid, 2- heteroarylalkenyl derivatives as therapeutic agents |
| CZ305221B6 (cs) * | 2013-12-10 | 2015-06-17 | Univerzita Pardubice | Způsob přípravy (3aR,4S,5R,6aS)-4-[(3S)-5-cyklohexyl-3-hydroxypent-1-yn-1-yl]-5-(ethoxymethoxy)-hexahydro-2H-cyklopenta[b]furan-2-onu |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3843713A (en) * | 1972-04-05 | 1974-10-22 | Ciba Geigy Corp | 16-lower alkoxy lower alkyl,-16-20 w-pentano,pge |
| GB1425961A (en) * | 1972-04-13 | 1976-02-25 | Erba Carlo Spa | Prostanoic acid derivatives |
| US3876690A (en) * | 1973-05-11 | 1975-04-08 | American Cyanamid Co | 1-alkoxy-9-keto-prostenoic acid derivatives |
| US3884909A (en) * | 1973-09-24 | 1975-05-20 | Standard Brands Inc | Gelatinizable crosslinked cationic starch and method for its manufacture |
| HU176654B (en) * | 1974-09-06 | 1981-04-28 | Erba Farmitalia | Process for producing pgf beta-prostaglandines |
| FI71138C (fi) * | 1976-12-31 | 1986-11-24 | Erba Farmitalia | Foerfarande foer framstaellning av terapeutiskt aktiva bisykliska prostaglandiner |
-
1974
- 1974-09-25 IT IT27654/74A patent/IT1053781B/it active Protection Beyond IP Right Term
-
1975
- 1975-08-06 GB GB32897/75A patent/GB1483880A/en not_active Expired
- 1975-08-06 CY CY954A patent/CY954A/xx unknown
- 1975-08-08 US US05/603,015 patent/US4035415A/en not_active Expired - Lifetime
- 1975-08-25 AT AT656075A patent/AT351184B/de active
- 1975-08-25 ZA ZA755420A patent/ZA755420B/xx unknown
- 1975-08-25 JP JP50102845A patent/JPS5839156B2/ja not_active Expired
- 1975-08-29 DK DK390975A patent/DK155316C/da not_active IP Right Cessation
- 1975-09-02 CS CS755964A patent/CS191276B2/cs unknown
- 1975-09-02 BE BE159667A patent/BE832983A/xx not_active IP Right Cessation
- 1975-09-03 DE DE2539116A patent/DE2539116C2/de not_active Expired
- 1975-09-03 HU HU75EA152A patent/HU174287B/hu unknown
- 1975-09-03 NO NO753028A patent/NO146357C/no unknown
- 1975-09-03 FR FR7527034A patent/FR2285866A1/fr active Granted
- 1975-09-03 SE SE7509764A patent/SE422057B/xx not_active IP Right Cessation
- 1975-09-03 IL IL48043A patent/IL48043A/xx unknown
- 1975-09-04 NL NLAANVRAGE7510452,A patent/NL187354C/xx not_active IP Right Cessation
- 1975-09-04 CA CA234,796A patent/CA1083569A/en not_active Expired
- 1975-09-04 SU SU752170657A patent/SU652889A3/ru active
- 1975-09-04 CH CH1149575A patent/CH617186A5/de not_active IP Right Cessation
- 1975-09-04 FI FI752491A patent/FI63932C/fi not_active IP Right Cessation
-
1978
- 1978-03-24 FR FR7808815A patent/FR2378757A1/fr active Granted
- 1978-06-27 KE KE2851A patent/KE2851A/xx unknown
- 1978-08-03 HK HK424/78A patent/HK42478A/xx unknown
- 1978-12-30 MY MY321/78A patent/MY7800321A/xx unknown
-
1979
- 1979-02-02 US US06/009,091 patent/US4361577A/en not_active Expired - Lifetime
-
1982
- 1982-09-16 JP JP57159690A patent/JPS5918391B2/ja not_active Expired
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SE429970B (sv) | Forfarande for framstellning av glukopyranosido-1,6-mannit | |
| SE423633B (sv) | Forfarande for framstellning av 4-demetoxi-daunomycin | |
| SE421919B (sv) | Forfarande for framstellning av 2-tetrahydrofurfuryl-6,7-bensomorfaner | |
| SE437930B (sv) | Forfarande for framstellning av en fast, vismuthaltig farmaceutisk komposition | |
| SE7508405L (sv) | Forfarande for framstellning av polyfenyloxid. | |
| SE7508406L (sv) | Forfarande for framstellning av polyfenylenoxid. | |
| RO72736A (ro) | Procedeu pentru prepararea unor 2-tetrahidrofurfuril-6,7-benzomorfani-5,9-beta-disubstituiti | |
| SE419750B (sv) | Forfarande for framstellning av 6-acyl-2,4-dialkyl-2-hydroxicyklohexan-1,35-trion | |
| SE431211B (sv) | Forfarande for framstellning av n-acylamino-alfa-arylacetamido-cefalosporiner | |
| SE7508074L (sv) | Forfarande for framstellning av stilbenderivat. | |
| SE421921B (sv) | Analogiforfarande for framstellning av pyridobensodiazepinoner | |
| SE418615B (sv) | Analogiforfarande for framstellning av tetracykliska piperidinderivat | |
| SE418292B (sv) | Forfarande for framstellning av 5-aryl-2-furamidiner | |
| SE421612B (sv) | Forfarande for framstellning av alfa-6-deoxi-5-hydroxitetracyklin | |
| SE429237B (sv) | Forfarande for framstellning av 9,3",4"-tri-alkanoyl sf-837 m,-derivat | |
| SE400960B (sv) | Forfarande for framstellning av alh3 (po4)2 3h2o | |
| SE414926B (sv) | Forfarande for framstellning av 1-alkyl-2-(fenoximetyl)-5-nitroimidazoler | |
| SE422210B (sv) | Analogiforfarande for framstellning av substituerade indoler | |
| SE415658B (sv) | Analogiforfarande for framstellning av linnolinderivat | |
| SE404364B (sv) | Forfarande for framstellning av vissa angivna 5-sulfonylfenyl-tetrazolderivat | |
| SE425784B (sv) | Analogiforfarande for framstellning av eburnameninderivat | |
| NO139684C (no) | Fremgangsmaate for fremstilling av n,n-diallyldikloracetamid | |
| SE421310B (sv) | Forfarande for framstellning av substituerade bensoylpyridiner | |
| SE408898B (sv) | Foerfarande foer framstaelling av en 17-monoester av 17alfa, 21-dihydroxisteroider | |
| SE427032B (sv) | Forfarande for framstellning av 4-nitro-n-metylftalimid |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| NAL | Patent in force |
Ref document number: 7509764-2 Format of ref document f/p: F |
|
| NUG | Patent has lapsed |
Ref document number: 7509764-2 Format of ref document f/p: F |